CDT Equity Inc. (CDT) stock
CDTNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CDTTW
$0.44−0.07 (-13.10%)
Close on Nov 12, 2026Market cap $348.65KP/E –Yield –
CDT Equity cash
Cash and short-term investments held at the end of each period.
CDT Equity's cash was $700.00K at Jun 30, 2026. For fiscal 2025 it was $1.50M, up 150.0% from the year before. The highest annual figure on record is $8.43M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.50M | +150.0% |
| FY2024 | Dec 31, 2024 | $600.00K | -92.9% |
| FY2023 | Dec 31, 2023 | $8.43M | +2337.4% |
| FY2022 | Dec 31, 2022 | $345.78K | +612.1% |
| FY2021 | Dec 31, 2021 | $48.56K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $700.00K | -79.0% |
| Q1 FY2026 | Mar 31, 2026 | $100.00K | -96.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.50M | +150.0% |
| Q3 FY2025 | Sep 30, 2025 | $3.84M | +5305.6% |
| Q2 FY2025 | Jun 30, 2025 | $3.33M | +1421.5% |
| Q1 FY2025 | Mar 31, 2025 | $2.73M | +48.0% |
| Q4 FY2024 | Dec 31, 2024 | $600.00K | -92.9% |
| Q3 FY2024 | Sep 30, 2024 | $71.00K | -99.2% |
| Q2 FY2024 | Jun 30, 2024 | $219.00K | -21.2% |
| Q1 FY2024 | Mar 31, 2024 | $1.84M | +1935.2% |
| Q4 FY2023 | Dec 31, 2023 | $8.43M | +2337.4% |
| Q3 FY2023 | Sep 30, 2023 | $8.64M | +1087.2% |
| Q2 FY2023 | Jun 30, 2023 | $277.76K | -66.8% |
| Q1 FY2023 | Mar 31, 2023 | $90.61K | -90.6% |
| Q4 FY2022 | Dec 31, 2022 | $345.78K | +612.1% |
| Q3 FY2022 | Sep 30, 2022 | $728.07K | – |
| Q2 FY2022 | Jun 30, 2022 | $837.69K | – |
| Q1 FY2022 | Mar 31, 2022 | $964.60K | – |
| Q4 FY2021 | Dec 31, 2021 | $48.56K | – |
See a number that looks wrong?